Loading clinical trials...

A Study of BRII-296 in Adults With Severe Postpartum Depression (PPD) | Clinical Trials | Clareo Health

COMPLETEDPhase 2NCT06057012

A Study of BRII-296 in Adults With Severe Postpartum Depression (PPD)

The primary purpose of this study is to evaluate the safety and tolerability of BRII-296 administered by 2 intramuscular injections, administered with Depo Medrol as assessed by the incidence of adver...

Lead sponsor: Brii Biosciences Limited•11 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

COMPLETEDPhase 2

A Study to Evaluate SAGE-547 in Participants With Severe Postpartum Depression

NCT02614547 · Severe Postpartum Depression

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: January 27, 2025Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE2

Enrollment11

Start dateSep 2023

Last updatedJan 27, 2025

Condition

Severe Postpartum Depression

Locations shown

Cenexel CNR

Sherman Oaks, California

CenExel CNS-Torrance

Torrance, California

Clinical Research Center of Florida

Boynton Beach, Florida

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 27, 2025Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions